Atrial Fibrillation Ablation Needs a Smarter Solution

Atrial fibrillation (AFib) affects millions worldwide, with current catheter ablation procedures often challenged by incomplete lesion formation, prolonged operation times, and operator variability. Conventional RF and balloon-based technologies each offer benefits but fall short in delivering consistently safe, effective outcomes.

The Challenge

Standard ablation tools often force clinicians to choose between precision and ease of use. RF catheters may provide focal control but can struggle with lesion completeness and contact quality. Balloon-based devices simplify deployment but lack the finesse for targeted ablation. The clinical community faces a pressing need for a tool that combines the strengths of both approaches while minimizing limitations.

The Solution

Hyblate’s innovative “hybrid” ablation catheter merges the advantages of RF ablation with balloon catheter functionality to address the limitations of existing tools:

• Improved tissue contact for safer, more effective energy delivery
• Circumferential and focal RF ablation for complete, durable lesions
• Easy balloon deployment for smoother operation and reduced procedure time

By enhancing lesion quality, streamlining workflows, and enabling more consistent results across operators, Hyblate aims to raise the standard of care in AFib treatment.